Pain AND Opioids After Surgery (PANDOS)

November 16, 2026 updated by: University of Aberdeen

Pain and Opioids After Surgery (PANDOS) Study

The aim of this study is to document the perioperative opioid use and its safety in the UK and countries in Europe and to describe its association with surgical complications, persistent pain and quality of life. In an international, prospective, observational cohort study, data about the perioperative pain management will be collected in all eligible hospitalised adult patients who undergo surgery in a designated "study week" in as many hospitals as possible in Europe. Baseline data will be collected, and participants followed up at one week, and at three and twelve months post-operatively. The primary outcome will be opioid use at three months after surgery. Secondary outcomes will include opioid use during the preoperative month (preoperative use), during surgery and up to one week after surgery (or discharge, whichever is earlier), and up to the end of the postoperative year. Additional secondary outcomes are the incidence of preoperative pain, persistent pain with/without the presence of neuropathic components, quality of life and surgical complications. The potential association between opioid use and pain outcomes will be investigated. This study could help to develop strategies to improve quality of care, through pain management, for patients undergoing surgery.

Study Overview

Detailed Description

PANDOS is an international, prospective, observational cohort study. In a one week period (the designated "study week"), data will be collected in all eligible hospitalised adult patients who undergo surgery in as many hospitals as possible in the UK and Europe. Participants will be followed up for 12 months

Study Type

Observational

Enrollment (Actual)

8975

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Vinogradska 29
      • Zagreb, Vinogradska 29, Croatia, 10000
        • Department of Anaesthesiology Sestre Milosrdnice, University Hospital Center
      • Aberdeen, United Kingdom
        • NHS Grampian
      • London, United Kingdom
        • University College London Hospitals NHS Foundation Trust
      • Nottingham, United Kingdom
        • Kings Mill Hospital, Sherwood Forest Hospitals NHS Foundation Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All eligible patients undergoing surgery at the hospital during the designated study week

Description

Inclusion Criteria:

  • hospitalised adult patients (18 years and older) undergoing any inpatient surgery (elective or emergency) during the designated study week where an anaesthetist is involved (general anaesthetic, sedation, local anaesthetic).

Able to understand and has capacity to give written informed consent

Exclusion Criteria:

  • American Society of Anaesthesiologists (ASA) grade V or VI
  • Refusal to participate.
  • Lack of comprehension of validated questionnaires or inability to complete the follow-up for any reason.
  • Lack of capacity to give written informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: ECOLOGIC_OR_COMMUNITY
  • Time Perspectives: PROSPECTIVE

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient reported Opioid use post surgery
Time Frame: 3 months

Patient reported use of opioids post surgery

3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Opioid use
Time Frame: From recruitment to 1 year post surgery

Patient reported use of opioids pre-op and opioids used during surgery and prescribed post surgery

From recruitment to 1 year post surgery
Patient reported incidence of pain pre-op and post surgery using BPI-SF
Time Frame: From recruitment to 1 year post surgery

Patient reported incidence of pain pre-op and post surgery using BPI-SF

From recruitment to 1 year post surgery
Patient reported incidence of pain pre-op and post surgery using DN2
Time Frame: From recruitment to 1 year post surgery

Patient reported incidence of pain pre-op and post surgery using DN2

From recruitment to 1 year post surgery
Surgical complications
Time Frame: During surgery

Recording of surgical complications during surgery

During surgery
Participant reported quality of life EQ5D-5L
Time Frame: From recruitment to 1 year post surgery

EQ5D-5L

From recruitment to 1 year post surgery
Participant reported quality of life BPI-SF
Time Frame: From recruitment to 1 year post surgery

BPI-SF

From recruitment to 1 year post surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Patrice Forget, University of Aberdeen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 25, 2023

Primary Completion (Actual)

May 30, 2026

Study Completion (Actual)

May 30, 2026

Study Registration Dates

First Submitted

April 6, 2023

First Submitted That Met QC Criteria

May 23, 2023

First Posted (Actual)

May 26, 2023

Study Record Updates

Last Update Posted (Actual)

November 19, 2026

Last Update Submitted That Met QC Criteria

November 16, 2026

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe